Hypothermia remains effective in cardiac arrest patients with preexisting cardiomyopathyNovember 14, 2011
Cardiomyopathy is common among cardiac arrest survivors. The survival and neuroprotective benefits of therapeutic hypothermia is similar in patients with preexisting cardiomyopathy, compared with those patients without cardiomyopathy, according to a scientific poster being presented Nov. 14 at the at the American Heart Association (AHA) scientific sessions in Orlando, Fla. Therefore, the researchers recommended the use of therapeutic hypothermia in patients with the preexisting condition.
"While it is well established that therapeutic hypothermia is neuroprotective and increases survival in resuscitated cardiac arrest patients without cardiomyopathy, we sought to determine whether catastrophic outcomes in cardiac arrest patients with preexisting cardiomyopathy are avoidable," said Michael R. Mooney, MD, a cardiologist at the Minneapolis Heart Institute® at Abbott Northwestern Hospital in Minneapolis and physician researcher with Minneapolis Heart Institute Foundation.
From February 2006 to July 2010, Mooney and his colleagues enrolled 192 consecutive cardiac arrest patients who remained unresponsive following return of spontaneous circulation in a therapeutic hypothermia protocol, regardless of initial rhythm, hemodynamic status or prior medical history. They hypothesized that there would be a high prevalence of preexisting cardiomyopathy in this patient population, and therapeutic hypothermia would confer similar neurologic and survival benefit compared to non-cardiomyopathy patients.
Of the 192 patients, 43.8 percent had preexisting cardiomyopathy, of which ischemic was the most common type (41.7 percent). Patients with preexisting cardiomyopathy were older (65.7 years vs. 61.7 years) and more likely to be male (83.3 vs. 63.9 percent).
The majority presented in ventricular fibrillation/ventricular tachycardia (75 percent and 70.4 percent) in both the cardiomyopathy and non-cardiomyopathy groups. There was a higher prevalence of concurrent STEMI in the cardiomyopathy group (27 vs. 18.5 percent), which was not statistically significantly. Cardiogenic shock was more prevalent in the cardiomyopathy group (54.8 vs. 28.7 percent).
While the cardiomyopathy groups were slightly higher, the survival between the two groups (52.4 vs. 51.9 percent) and survival with favorable neurologic outcome, defined by Cerebral Performance Category 1 or 2, (46.4 vs. 49.1 percent), were similar. They found that survival with favorable neurologic outcome in cardiomyopathy patients with cardiogenic shock was 34.8 percent, compared with 45.2 percent in non-cardiomyopathy cardiogenic shock patients.
"The incidence of preexisting heart dysfunction in this observational study is alarming. In general, we need to employ a more careful surveillance and improve our adherence to the clinical guidelines, as less than 50 percent of patients who currently qualify for automatic implantable cardioverter-defibrillators actually receive them," Mooney said. "A great deal more research is warranted in assessing this patient population."
The Minneapolis Heart Institute® is recognized internationally as one of the world's leading providers of heart and vascular care. This state-of-the-art facility combines the finest in personalized patient care with sophisticated technology in a unique, family-oriented environment. The Institute's programs, a number of which are conducted in conjunction with Abbott Northwestern Hospital, address the full range of heart and vascular health needs: prevention, diagnosis, treatment and rehabilitation.
Minneapolis Heart Institute Foundation
The Minneapolis Heart Institute Foundation is dedicated to creating a world without heart disease through groundbreaking clinical research and innovative education programs. MHIF's mission is to promote and improve cardiovascular health, quality of life and longevity for all.
Minneapolis Heart Institute Foundation
Related Cardiomyopathy Articles:
Researchers in the UK and Peru have developed a faster and cheaper cardiac imaging test that can be used in developing countries, according to the results of the INCA-Peru study presented today at EuroCMR 2017.
Men seem to have worse chemotherapy-induced cardiomyopathy than women despite receiving similar cancer treatments, according to research presented today at EuroCMR 2017.
The Spectrum Health Hypertrophic Cardiomyopathy Program has been designated a national Center of Excellence by the Hypertrophic Cardiomyopathy Association (HCMA).
Peripartum cardiomyopathy occurs globally and is not a disease of the poor, according to research published today in the European Journal of Heart Failure.
Early screening for a genetic variant that predisposes people of South Asian descent to hypertrophic cardiomyopathy (an enlarged heart) could help reduce the incidence of sudden cardiac death in this population, says a University of Cincinnati College of Medicine heart researcher.
Younger marijuana users were twice as likely as non-users to experience stress cardiomyopathy, a sudden, usually temporary, weakening of the heart muscle that occurs more commonly in older women.
Sudden death in patients with hypertrophic cardiomyopathy (HCM) is rarely associated with exercise, according to research presented at ESC Congress 2016 today by Dr.
Sudden deaths in young, seemingly healthy competitive athletes are tragic events.
Cardiomyopathy, or a deterioration of the ability of the heart muscle to contract, generally leads to progressive heart failure.
Jose Pinto, a researcher in the Florida State University College of Medicine, will use a $1.8 million National Institutes of Health grant to study how the heart's calcium is regulated and how to correct a calcium imbalance using an inside approach in the cardiac cell.
Related Cardiomyopathy Reading:
A Guide to Hypertrophic Cardiomyopathy: For Patients, Their Families and Interested Physicians
by Barry J. Maron (Author), Lisa Salberg (Author), Eugene Braunwald (Foreword)
Written by the authority on hypertrophic cardiomyopathy (HCM) and an HCM patient, and fully endorsed by the Hypertrophic Cardiomyopathy Association (HCMA), the leading advocacy and support organization, the 3rd Edition of this best-selling guide offers unparalleled insight into all aspects of living with and treating HCM.
Accessible and practical, A Guide to Hypertrophic Cardiomyopathy For Patients, Their Families and Interested Physicians 3rd Edition:Answers the most pressing questions posed by patients, their families, and non-specialists
health professionals... View Details
Six Months to Live...: my Cardiomyopathy story of Mind over Medicine (Volume 1)
by Ms Margot Maurice (Author), Ms Margot Maurice (Contributor), Dr Steven J Sommer (Contributor), Mr John Gallagher (Contributor)
Six Months to Live was the prognosis given to the author in 1984. Still here in 2015, proves that not all prognoses are correct and it is often helped by recognition of the influence of the mind in healing the body. View Details
by Robert Pensack (Author), Dwight Williams (Collaborator)
A forty-three-year-old physician describes how he was diagnosed with an often fatal cardiac condition at age fifteen and presents poignant memoir of his struggle to become a doctor, raise of family, and, most of all, value life despite adversity. View Details
Hypertrophic Cardiomyopathy: Foreword by Bernard Gersh and Historical Context by Eugene Braunwald
by Srihari S. Naidu (Editor)
This book provides a comprehensive clinical review of Hypertrophic Cardiomyopathy (HCM), the most common genetic disorder of the heart characterized by dysfunctional contractility at the sarcomere level, resulting in the development of abnormal and occasionally focal hypertrophy on a macroscopic level.
Editor, Srihari S. Naidu, has brought together a world renowned group of experts to review various different topics but, with a practical focus that will enable readers to establish the evidence-based best practice in any potential scenario. Treatment modalities including medications,... View Details
Hypertrophic Cardiomyopathy: For Patients, Their Families and Interested Physicians
by Barry J. Maron (Author), Lisa Salberg (Author)
When there is a diagnosis of HCM in a family, this complete, easy-to-read guide is your essential resource for finding the answers to your many questions. In clear and straightforward language, it explains what hypertrophic cardiomyopathy is, what the symptoms are, and how it can be treated, as well as reviewing the genetic implications and offering candid lifestyle advice.
Drawing on the expertise of Dr. Barry Maron, an internationally recognized authority on HCM, the book addresses major questions and concerns of both patients and families. Fully revised to reflect... View Details
The Gene: An Intimate History
by Siddhartha Mukherjee (Author)
THE #1 NEW YORK TIMES BESTSELLER
A New York Times Notable Book
A Washington Post and Seattle Times Best Book of the Year
From the Pulitzer Prize-winning author of The Emperor of All Maladies—a fascinating history of the gene and “a magisterial account of how human minds have laboriously, ingeniously picked apart what makes us tick” (Elle).
“Dr. Siddhartha Mukherjee dazzled readers with his Pulitzer Prize-winning The Emperor of All Maladies in 2010. That achievement was evidently just a warm-up for... View Details
by Donald V. Unverferth (Editor)
Book by View Details
Arrhythmias in Cardiomyopathies, An Issue of Cardiac Electrophysiology Clinics, 1e (The Clinics: Internal Medicine)
by Mohammad Shenasa MD (Author)
This issue of Cardiac Electrophysiology Clinics examines Arrhythmias in Cardiomyopathies. Articles include Atrial and Ventricular Arrhythmias in Hypertrophic Cardiomyopathy and Its Variants; Role of Cardiac MRI in Risk Stratification of Hypertrophic Cardiomyopathy; Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy; Exercise-Induced Right Ventricular Cardiomyopathy; Dilated Cardiomyopathy; Sarcoidosis; Amyloidosis; Chagas Disease; Fabry Disease; Left Ventricular Hypertrophy: Ventricular Arrhythmias and SCD; Left Ventricular Non-compaction; Mitochondrial Cardiomyopathy and Related... View Details
Progressive Care Nursing Certification: Preparation, Review, and Practice Exams
by Thomas Ahrens (Author)
The best review available for Progressive Care certification!
CD-ROM with 2 comprehensive practice exams
Progressive Care Nursing Certification is a complete step-by-step guide that thoroughly covers everything you need to know to pass the examination administered by the American Association of Critical Care Nurses (AACN).
Presented in short, easy-to-read chapters, the book includes subject-specific practice exams, allowing you to target your study and quickly identify weak areas. In addition, the handy “Editor’s Note” highlights... View Details
Cardiac MRI in Diagnosis, Clinical Management, and Prognosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
by Aiden Abidov (Author), Isabel Oliva (Author), Frank I Marcus (Author)
Cardiac MRI in Diagnosis, Clinical Management and Prognosis of Arrhythmogenic Right Ventricular Cardiomyopathy / Dysplasia provides up-to-date information regarding the most effective diagnostic protocols and CMR sequences for the evaluation of patients with suspected or known ARVC/D. It includes CMR protocol summaries and clinical algorithms presented as flow diagrams, many of which have never been previously published. The book contains case reports from the practice and database of Dr. Frank I. Marcus, world renowned ARVC/D expert; as well as input from imaging experts... View Details